Benzinga | Oct 2, 2020 04:56AM EDT

JP Morgan Upgrades Pacific Biosciences to Overweight, Announces $15 Price Target

JP Morgan analyst Tycho Peterson upgrades Pacific Biosciences (NASDAQ:PACB) from Neutral to Overweight and announces $15 price target.